Fresenius Medical Care Sees U.S. Plans for Kidney Disease as Positive
As a health professional, you need the leading dialysis products, renal pharmaceuticals and critical care solutions. Let's work together to find you the tools you need, so you can deliver the best care for patients.
Power your practice with our resources. We're here to help support your patients and your thriving practice.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
Success! The link has been copied to your clipboard.
Cigna is aiming to avoid unnecessary hospitalizations for people on dialysis at clinics run by Fresenius Medical Care and others who are covered by Cigna insurance.
If Fresenius Health Partners, the care management arm of the multinational company, is able to reduce overall costs, Cigna and Fresenius will share in the savings. Fresenius cares for approximately 180,000 people throughout the United States, about a third of the total dialysis market.
Although Fresenius Medical Care is one of the big two dialysis chains, Cigna is only responsible for about 1,100 people at their centers.
About 85 percent of all Americans on dialysis are covered by Medicare. The government health program is open to all with end-stage renal disease, even if they are not yet 65.
Fresenius has more than 10 years of experience working to lower the cost of care by improving the management of patients’ chronic illnesses, starting with Medicare.
Read full story at Courant.com.
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com.